Teva And Alvotech Strike US Biosimilars Pact

Deal Covers Five Biosimilar Candidates With $35bn Brand Value

 
• By Dave Wallace

Teva and Alvotech have announced a major biosimilars alliance covering five products for the US market.

Hand - USA
The US deal covers five biosimilar candidates • Source: Shutterstock

More from Deals

More from Business